ARUP Newsroom

Representative Blake Moore (R-Utah, District 1) speaks during a House Committee on Ways and Means hearing held at ARUP Laboratories. Pictured from left to right are Celeste Maloy (R-Utah, District 2), Burgess Owens (R-Utah, District 4), Moore, Jason Smith (R-Missouri, District 8), and Brad Wenstrup, MD (R-Ohio, District 2).

Rep. Blake Moore (R-UT) and other members of the Ways and Means Committee’s Health Subcommittee will participate in a field hearing on July 12 at ARUP Laboratories.

Karen Brisendine currently works as a technologist in ARUP’s Mycology Acid-Fast Bacilli (AFB) Lab, but she has worked in many departments at ARUP since she started with the company at its founding in 1984. Along the way, she has learned more about herself and discovered a passion for laboratory science.

Andy Theurer, ARUP CEO, speaks to a crowd gathered to celebrate ARUP’s 40th anniversary. Others on stage include, from left to right, Tracy I. George, MD, ARUP chief scientific officer and president of the Innovation Business Unit, Julio C. Delgado, MD, MS, ARUP executive vice president and vice chair and chief of Clinical Pathology at the University of Utah, and Carl R. Kjeldsberg, MD, an ARUP founder and former CEO.

Presentations and posters will cover topics such as mycobacterial infections, increasing rates of macrolide drug resistance, the state of parasitology following the COVID-19 pandemic, and more.

Kara Oliver was diagnosed with Ewing sarcoma in 2023.

ARUP Laboratories has filed a declaration supporting a lawsuit against the FDA brought by the American Clinical Laboratory Association.

Jonathan Genzen, MD, PhD, ARUP’s chief medical officer and senior director of governmental affairs, and Jonathan Carr, JD, chief compliance officer, discuss the FDA’s final rule on LDTs.